Back
Marinus Pharmaceuticals Stock Price Chart
Sponsored
MRNS
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
MRNS
Marinus Pharmaceuticals
Last Price:
$0.26
Seasonality Move:
10.25%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight buying pressure.
Marinus Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.25 | Buy |
20-day SMA: | 0.28 | Sell |
50-day SMA: | 0.51 | Sell |
200-day SMA: | 2.07 | Sell |
8-day EMA: | 0.25 | Buy |
20-day EMA: | 0.29 | Sell |
50-day EMA: | 0.53 | Sell |
200-day EMA: | 2.29 | Sell |
Marinus Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 32.68 | Sell |
Chaikin Money Flow: | 294080 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.26 - 0.32) | Sell |
Bollinger Bands (100): | (0.37 - 1.61) | Sell |
Marinus Pharmaceuticals Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Marinus Pharmaceuticals Stock
Is Marinus Pharmaceuticals Stock a Buy?
-
Marinus Pharmaceuticals share price is 0.26 while MRNS 8-day simple moving average is 0.25, which is a Buy signal.
-
The stock price of MRNS is 0.26 while Marinus Pharmaceuticals 20-day SMA is 0.28, which makes it a Sell.
-
Marinus Pharmaceuticals 50-day simple moving average is 0.51 while MRNS share price is 0.26, making it a Sell technically.
-
MRNS stock price is 0.26 and Marinus Pharmaceuticals 200-day simple moving average is 2.07, creating a Sell signal.
MRNS Technical Analysis vs Fundamental Analysis
Sell
41
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy or a Sell?
-
Marinus Pharmaceuticals stock is rated a SellThe current Marinus Pharmaceuticals [MRNS] share price is $0.26. The Score for MRNS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Marinus Pharmaceuticals Stock Info
Market Cap:
14.2M
Price in USD:
0.26
Share Volume:
579K
Marinus Pharmaceuticals 52-Week Range
52-Week High:
11.26
52-Week Low:
0.22
Sell
41
Marinus Pharmaceuticals (MRNS)
is a Sell
Marinus Pharmaceuticals Share Price Forecast
-
What is the Marinus Pharmaceuticals stock price today?The Marinus Pharmaceuticals stock price is 0.26 USD today.
-
Will MRNS stock go up or go down?Marinus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Marinus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marinus Pharmaceuticals is overvalued.
Is Marinus Pharmaceuticals Stock a Buy?
-
Marinus Pharmaceuticals share price is 0.26 while MRNS 8-day exponential moving average is 0.25, which is a Buy signal.
-
The stock price of MRNS is 0.26 while Marinus Pharmaceuticals 20-day EMA is 0.29, which makes it a Sell.
-
Marinus Pharmaceuticals 50-day exponential moving average is 0.53 while MRNS share price is 0.26, making it a Sell technically.
-
MRNS stock price is 0.26 and Marinus Pharmaceuticals 200-day simple moving average is 2.29, creating a Sell signal.
Fundamental Analysis of Marinus Pharmaceuticals
Is Marinus Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and an increase next year of $1.28 per share.
Technical Analysis of Marinus Pharmaceuticals
Should I short Marinus Pharmaceuticals stock?
-
MRNS Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Marinus Pharmaceuticals is a Sell
-
Marinus Pharmaceuticals Relative Strength Index (RSI) is 32.68, which suggest Marinus Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Marinus Pharmaceuticals is (0.26 - 0.32), which suggest Marinus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Marinus Pharmaceuticals is (0.37 - 1.61), which suggest Marinus Pharmaceuticals is a Sell
* Marinus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.